NDUFAF4 (NADH:Ubiquinone Oxidoreductase Complex Assembly Factor 4) is a critical protein involved in the assembly of mitochondrial Complex I, part of the electron transport chain. While no direct reference to a "FAF4 antibody" exists in the search results, studies on its Drosophila homolog dNDUFAF4 (referred to as FAF4-kd in knockdown models) highlight its role in maintaining Complex I stability .
Structural Impact: Knockdown of dNDUFAF4 in Drosophila thoraces reduces Complex I activity by 35–40% and destabilizes subcomplexes (e.g., P P-a and P P-b modules) .
Functional Redundancy: Both dNDUFAF3 and dNDUFAF4 knockdowns show overlapping but non-identical effects on mitochondrial function, suggesting partial redundancy .
| Parameter | FAF4-Knockdown (FAF4-kd) | Wild-Type Control |
|---|---|---|
| Complex I Activity | Reduced by ~40% | Normal activity |
| Subcomplex Stability | Accretion of P P-a/P P-b modules | Stable assembly |
| OXPHOS Complexes | CII–CV unaffected | Normal assembly |
A commercially available monoclonal antibody (Clone N56/21) targets FGF14 (also termed FHF4), a neuronal protein regulating sodium channels. While distinct from "FAF4," this antibody is explicitly validated for research applications .
Though unrelated to "FAF4," anti-PF4 (platelet factor 4) antibodies are extensively studied in heparin-induced thrombocytopenia (HIT) and vaccine-induced thrombotic thrombocytopenia (VITT). These antibodies exhibit prolonged persistence (up to 15 months post-diagnosis) and are detected via ELISA or functional assays .
Ambiguity in Terminology: The term "FAF4" may stem from typographical errors (e.g., FGF14, FABP4, or NDUFAF4). None of the sources explicitly describe a "FAF4 antibody."
Research Gaps: No studies in the provided materials focus on developing or characterizing an antibody specifically against a protein named "FAF4."
Verify the intended target (e.g., NDUFAF4, FGF14, or FABP4) to align with established antibody databases.
Explore proteomic repositories (e.g., UniProt, Antibodypedia) for commercial antibodies against NDUFAF4 or homologs.